Tucidinostat Plus R-CHOP Improves EFS in DLBCL Expressing MYC and BCL2

Tucidinostat plus R-CHOP improved efficacy and was safe in previously untreated DLBCL expressing MYC and BCL2.

Related Keywords

China ,Shanghai ,Weili Zhao ,Shanghai Institute Of Hematology ,Key Laboratory Of Medical Genomics ,International Prognostic Index ,National Research Center ,Shanghai Institute ,State Key Laboratory ,Medical Genomics ,Translational Medicine ,Ruijin Hospital Affiliated ,Shanghai Jiao Tong University School ,